153 related articles for article (PubMed ID: 24776816)
21. The COMT and DRD3 genes interacted in bipolar I but not bipolar II disorder.
Lee SY; Chen SL; Chen SH; Huang SY; Tzeng NS; Chang YH; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
World J Biol Psychiatry; 2011 Aug; 12(5):385-91. PubMed ID: 20698735
[TBL] [Abstract][Full Text] [Related]
22. Preliminary evidence for association between schizophrenia and polymorphisms in the regulatory Regions of the ADRA2A, DRD3 and SNAP-25 Genes.
Lochman J; Balcar VJ; Sťastný F; Serý O
Psychiatry Res; 2013 Jan; 205(1-2):7-12. PubMed ID: 22940547
[TBL] [Abstract][Full Text] [Related]
23. DRD3 variation associates with early-onset heroin dependence, but not specific personality traits.
Kuo SC; Yeh YW; Chen CY; Huang CC; Chang HA; Yen CH; Ho PS; Liang CS; Chou HW; Lu RB; Huang SY
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():1-8. PubMed ID: 24398431
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
[TBL] [Abstract][Full Text] [Related]
25. Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients.
Liu YZ; Tang BS; Yan XX; Liu J; Ouyang DS; Nie LN; Fan L; Li Z; Ji W; Hu DL; Wang D; Zhou HH
Eur J Clin Pharmacol; 2009 Jul; 65(7):679-83. PubMed ID: 19396436
[TBL] [Abstract][Full Text] [Related]
26. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.
McGuire V; Van Den Eeden SK; Tanner CM; Kamel F; Umbach DM; Marder K; Mayeux R; Ritz B; Ross GW; Petrovitch H; Topol B; Popat RA; Costello S; Manthripragada AD; Southwick A; Myers RM; Nelson LM
J Neurol Sci; 2011 Aug; 307(1-2):22-9. PubMed ID: 21663922
[TBL] [Abstract][Full Text] [Related]
27. Association of the DRD2 CA
Xu S; Liu J; Yang X; Qian Y; Xiao Q
J Neurol Sci; 2017 Jan; 372():433-438. PubMed ID: 27817855
[TBL] [Abstract][Full Text] [Related]
28. ABCB1 and DRD3 polymorphism as a response predicting biomarker and tool for pharmacogenetically guided clozapine dosing in Asian Indian treatment resistant schizophrenia patients.
M N; Patil AN; Pattanaik S; Kaur A; Banerjee D; Grover S
Asian J Psychiatr; 2020 Feb; 48():101918. PubMed ID: 31896438
[TBL] [Abstract][Full Text] [Related]
29. No association between the DRD3 Ser9Gly polymorphism and schizophrenia.
Fathalli F; Rouleau GA; Xiong L; Tabbane K; Benkelfat C; Deguzman R; Zoltan D; Lal S; D'cruz S; Joober R
Schizophr Res; 2008 Jan; 98(1-3):98-104. PubMed ID: 17698325
[TBL] [Abstract][Full Text] [Related]
30. Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms.
Hassan A; Heckman MG; Ahlskog JE; Wszolek ZK; Serie DJ; Uitti RJ; van Gerpen JA; Okun MS; Rayaprolu S; Ross OA
Parkinsonism Relat Disord; 2016 Jan; 22():102-5. PubMed ID: 26627941
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of six genes (BDNF, DRD1, DRD3, DRD4, GRIN2B and MAOA) involved in neuroplasticity and the risk for alcohol dependence.
Forero DA; López-León S; Shin HD; Park BL; Kim DJ
Drug Alcohol Depend; 2015 Apr; 149():259-63. PubMed ID: 25660313
[TBL] [Abstract][Full Text] [Related]
32. The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients With Bipolar II Disorder.
Chang TT; Chen SL; Chang YH; Chen PS; Chu CH; Chen SH; Huang SY; Tzeng NS; Wang LJ; Wang TY; Li CL; Chung YL; Hsieh TH; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB; Lee SY
Medicine (Baltimore); 2016 Jun; 95(24):e3488. PubMed ID: 27310943
[TBL] [Abstract][Full Text] [Related]
33. Association between oxytocin and receptor genetic polymorphisms and aggression in a northern Chinese Han population with alcohol dependence.
Yang L; Wang F; Wang M; Han M; Hu L; Zheng M; Ma J; Kang Y; Wang P; Sun H; Zuo W; Xie L; Wang A; Yu D; Liu Y
Neurosci Lett; 2017 Jan; 636():140-144. PubMed ID: 27818356
[TBL] [Abstract][Full Text] [Related]
34. Interaction of the DRD3 and BDNF gene variants in subtyped bipolar disorder.
Lee SY; Chen SL; Chen SH; Chu CH; Chang YH; Lin SH; Huang SY; Tzeng NS; Kuo PH; Lee IH; Yeh TL; Yang YK; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):382-7. PubMed ID: 22877924
[TBL] [Abstract][Full Text] [Related]
35. Association between the 5-HTR1B gene polymorphisms and alcohol dependence in a Han Chinese population.
Cao JX; Hu J; Ye XM; Xia Y; Haile CA; Kosten TR; Zhang XY
Brain Res; 2011 Feb; 1376():1-9. PubMed ID: 21172311
[TBL] [Abstract][Full Text] [Related]
36. Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission.
Loch AA; van de Bilt MT; Bio DS; Prado CM; de Sousa RT; Valiengo LL; Moreno RA; Zanetti MV; Gattaz WF
Braz J Psychiatry; 2015; 37(3):235-41. PubMed ID: 26376054
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of the influence of DRD3 Ser9Gly variant on susceptibility for essential tremor.
Mao X; Wang T; Liu M; Chang X; Li N; Gu Y; Zhao D; Liao Q; Peng R
J Clin Neurosci; 2013 Dec; 20(12):1644-9. PubMed ID: 24054403
[TBL] [Abstract][Full Text] [Related]
38. The genetic influence of the DRD3 rs6280 polymorphism (Ser9Gly) on functional connectivity and gray matter volume of the hippocampus in patients with first-episode, drug-naïve schizophrenia.
Kang Y; Zhang Y; Huang K; Wang Z
Behav Brain Res; 2023 Feb; 437():114124. PubMed ID: 36154848
[TBL] [Abstract][Full Text] [Related]
39. DRD3 Predicts Cognitive Impairment and Anxiety in Parkinson's Disease: Susceptibility and Protective Effects.
Gonçalves A; Mendes A; Damásio J; Vila-Chã N; Boleixa D; Leal B; Cavaco S
J Parkinsons Dis; 2024; 14(2):313-324. PubMed ID: 38363619
[TBL] [Abstract][Full Text] [Related]
40. No association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and schizophrenia in a Spanish sample.
Lorenzo CV; Baca-Garcia E; Hernandez MD; Martin CB; Perez-Rodriguez MM; Saiz-Gonzalez MD; Fernández P; Gutierrez FJ; Saiz-Ruiz J; Piqueras JF; de Rivera JL; de Leon J
Am J Med Genet B Neuropsychiatr Genet; 2007 Apr; 144B(3):344-6. PubMed ID: 17171662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
